OTCMKTS:PBSV Pharma-Bio Serv (PBSV) Stock Forecast, Price & News $1.03 +0.03 (+3.51%) (As of 04:15 PM ET) Add Compare Share Share Today's Range$0.99▼$1.0350-Day Range$0.85▼$1.0852-Week Range$0.68▼$1.20Volume5,008 shsAverage Volume5,218 shsMarket Capitalization$23.67 millionP/E Ratio14.71Dividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsDividendEarningsFinancialsHeadlinesSEC FilingsShort InterestProfileChartCompetitorsDividendEarningsFinancialsHeadlinesSEC FilingsShort Interest About Pharma-Bio Serv (OTCMKTS:PBSV) StockPharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm in the United States and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.Read More PBSV Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PBSV Stock News HeadlinesSeptember 18, 2023 | americanbankingnews.comPharma-Bio Serv, Inc. (OTCMKTS:PBSV) Forecasted to Earn Q1 2024 Earnings of $0.02 Per ShareSeptember 15, 2023 | finance.yahoo.comPBSV Boosts Margins and Expands MarketsSeptember 27, 2023 | Chaikin Analytics (Ad)Fox Couldn't Air my #1 A.I. Pick - Get it Here.50-year Wall Street Insider Marc Chaikin got invited onto Fox News to talk about A.I. - Here's what he couldn't say on television. More here.September 14, 2023 | finance.yahoo.comPharma-Bio Serv Announces Results for the Three and Nine Months Ended July 31, 2023August 31, 2023 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: BioMarin Pharmaceutical (BMRN) and Phibro Animal Health (PAHC)July 28, 2023 | thestreet.comPharma-Bio Serv IncJuly 17, 2023 | msn.comBridgeBio Pharma: Positive ATTR-CM Treatment Data Leads To Other 2023 CatalystsJuly 15, 2023 | marketwatch.comBridgeBio Pharma Shares Rise 14% on Expected Results from Heart-Disease StudySeptember 27, 2023 | Behind the Markets (Ad)66,000% upside on tiny biotech?The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.July 15, 2023 | marketwatch.comStocks to Watch: BridgeBio Pharma, Universal Security Instruments, BYND Cannasoft EnterprisesJune 20, 2023 | technews.tmcnet.comPearl Bio Secures Breakthrough IP for Multi-Functionalized BiologicsJune 15, 2023 | finance.yahoo.comPBSV: A Consistent Performer with Impressive DividendJune 14, 2023 | finance.yahoo.comPharma-Bio Serv Announces Results for the Three and Six Months Ended April 30, 2023June 13, 2023 | ca.finance.yahoo.comTBPMF - Tetra Bio-Pharma Inc.June 10, 2023 | finance.yahoo.comPBSV - Pharma-Bio Serv, Inc.May 20, 2023 | msn.comAvid Bioservices Bolsters Manufacturing Capabilities And Generates High-Demand ServicesMay 15, 2023 | tmcnet.comBridgeBio Pharma to Present Updated Data from itsMay 10, 2023 | marketwatch.comBio Pharma Buffer Market Research | 2023-2030May 9, 2023 | marketwatch.comGlobal "Bio Pharma Logistics Market" 2023 Research Report | Enhanced Growth Size, Estimates and Regional Outlook by 2030 | Research Reports WorldApril 25, 2023 | markets.businessinsider.comHere's what Wall Street expects from Biomarin Pharmaceutical's earningsApril 20, 2023 | benzinga.comPharma-Bio Serv Stock (OTC:PBSV), Quotes and News SummaryApril 8, 2023 | marketwatch.comBio Pharma Buffer Market 2023 Size and Forecast to 2031March 20, 2023 | finance.yahoo.comPBSV: A Steady Performer with Upside PotentialMarch 17, 2023 | finance.yahoo.comPharma-Bio Serv Announces Results for the Quarter Ended January 31, 2023March 7, 2023 | markets.businessinsider.com4 Analysts Have This to Say About BridgeBio PharmaMarch 3, 2023 | markets.businessinsider.comSVB Securities Keeps Their Buy Rating on BioMarin Pharmaceutical (BMRN)February 21, 2023 | marketwatch.comBio Pharma Buffer Market 2023: Emerging Trends and Best Practices in Futurism till 2028See More Headlines Receive PBSV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pharma-Bio Serv and its competitors with MarketBeat's FREE daily newsletter. Email Address PBSV Company Calendar Last Earnings9/14/2023Today9/27/2023Fiscal Year End10/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Management consulting services Sub-IndustryN/A SectorBusiness Services Current SymbolOTCMKTS:PBSV CUSIPN/A CIK1304161 Webwww.pharmabioserv.com Phone(787) 278-2709Fax787-796-5168Employees140Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.07 Trailing P/E Ratio14.71 Forward P/E Ratio11.44 P/E GrowthN/ANet Income$1.01 million Net Margins8.49% Pretax Margin10.91% Return on Equity9.36% Return on Assets7.51% Debt Debt-to-Equity RatioN/A Current Ratio8.05 Quick Ratio8.05 Sales & Book Value Annual Sales$19.40 million Price / Sales1.22 Cash Flow$0.05 per share Price / Cash Flow22.17 Book Value$0.70 per share Price / Book1.47Miscellaneous Outstanding Shares22,980,000Free Float20,226,000Market Cap$23.67 million OptionableNot Optionable Beta0.41 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Victor Sanchez (Age 52)CEO, Pres & Pres of European Operations Comp: $298.9kMr. Pedro J. Lasanta (Age 63)CFO, VP of Fin. & Admin. and Sec. Comp: $208.6kMs. Elizabeth Plaza (Age 59)Founder & Sr. Strategic Consultant Ms. Miriam Marrero M.B.A.HR Mang.Key CompetitorsAbri SPAC INASDAQ:ASPARyvylNASDAQ:RVYLATIFNASDAQ:ATIFCastellumNYSEAMERICAN:CTMAgileThoughtNASDAQ:AGILView All Competitors PBSV Stock - Frequently Asked Questions How have PBSV shares performed in 2023? Pharma-Bio Serv's stock was trading at $0.79 on January 1st, 2023. Since then, PBSV shares have increased by 30.4% and is now trading at $1.03. View the best growth stocks for 2023 here. Are investors shorting Pharma-Bio Serv? Pharma-Bio Serv saw a decline in short interest in the month of September. As of September 15th, there was short interest totaling 3,300 shares, a decline of 21.4% from the August 31st total of 4,200 shares. Based on an average trading volume of 3,800 shares, the days-to-cover ratio is currently 0.9 days. View Pharma-Bio Serv's Short Interest. How were Pharma-Bio Serv's earnings last quarter? Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) released its earnings results on Thursday, September, 14th. The company reported $0.02 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.02. The firm earned $4.58 million during the quarter, compared to the consensus estimate of $5.40 million. Pharma-Bio Serv had a trailing twelve-month return on equity of 9.36% and a net margin of 8.49%. How often does Pharma-Bio Serv pay dividends? What is the dividend yield for Pharma-Bio Serv? Pharma-Bio Serv announced a dividend on Wednesday, March 22nd. Shareholders of record on Wednesday, March 29th will be paid a dividend of $0.075 per share on Friday, April 14th. This represents a yield of 7.75%. The ex-dividend date of this dividend is Tuesday, March 28th. Read our dividend analysis for PBSV. What other stocks do shareholders of Pharma-Bio Serv own? Based on aggregate information from My MarketBeat watchlists, some companies that other Pharma-Bio Serv investors own include Zynerba Pharmaceuticals (ZYNE), Allena Pharmaceuticals (ALNA), AstroNova (ALOT), Oracle (ORCL), AT&T (T), Yintech Investment (YIN), Aeglea BioTherapeutics (AGLE), Ampliphi Biosciences (APHB), Carnival Co. & (CCL) and Earthstone Energy (ESTE). What is Pharma-Bio Serv's stock symbol? Pharma-Bio Serv trades on the OTCMKTS under the ticker symbol "PBSV." How do I buy shares of Pharma-Bio Serv? Shares of PBSV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Pharma-Bio Serv's stock price today? One share of PBSV stock can currently be purchased for approximately $1.03. How much money does Pharma-Bio Serv make? Pharma-Bio Serv (OTCMKTS:PBSV) has a market capitalization of $23.67 million and generates $19.40 million in revenue each year. The company earns $1.01 million in net income (profit) each year or $0.07 on an earnings per share basis. How many employees does Pharma-Bio Serv have? The company employs 140 workers across the globe. How can I contact Pharma-Bio Serv? Pharma-Bio Serv's mailing address is Pharma-Bio Serv Building Suite 6 Road 696, DORADO PR, 00646. The official website for the company is www.pharmabioserv.com. The company can be reached via phone at (787) 278-2709, via email at scottg@corprominence.com, or via fax at 787-796-5168. This page (OTCMKTS:PBSV) was last updated on 9/27/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharma-Bio Serv, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.